46.46.Z - Wholesale trade of pharmaceutical and medical products
20.42.Z - Manufacture of cosmetics and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.45.Z - Wholesale trade of perfumes and cosmetics
49.41.Z - Road freight transport
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
70.22.Z - Head office activities and management consultancy
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 9 | 15,6 | 72,9 |
EBITDA | 11,3 | 19 | 68 |
Short time liabilities | 95,8 | 84,9 | -11,4 |
Equity capital | 27,7 | 37,7 | 36,2 |
Operating profit (EBIT) | 9,5 | 16,7 | 76,6 |
Assets | 127,8 | 126,1 | -1,4 |
Net profit (loss) | 6,9 | 12,6 | 81,9 |
Cash | 1 | 1,3 | 21,7 |
Net income from sale | 315,7 | 378,3 | 19,8 |
Liabilities and provisions for liabilities | 100,1 | 88,3 | -11,8 |
Working assets | 111,9 | 109,2 | -2,4 |
Depreciation | 1,9 | 2,3 | 24,3 |
% | % | p.p. | |
Profitability of capital | 25 | 33,4 | 8,4 |
Equity capital to total assets | 21,7 | 29,9 | 8,2 |
Gross profit margin | 2,9 | 4,1 | 1,2 |
EBITDA Margin | 3,6 | 5 | 1,4 |
Days | Days | Days | |
Short term commitment turnover cycle | 111 | 82 | -29 |
Current financial liquidity indicator | 1.1532469987869263 | 1.2857239246368408 | 0,1 |
Net dept to EBITDA | 0.694517195224762 | 0.6834242939949036 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane